These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clinical events as a function of proton pump inhibitor use, clopidogrel use, and cytochrome P450 2C19 genotype in a large nationwide cohort of acute myocardial infarction: results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) registry. Simon T; Steg PG; Gilard M; Blanchard D; Bonello L; Hanssen M; Lardoux H; Coste P; Lefèvre T; Drouet E; Mulak G; Bataille V; Ferrières J; Verstuyft C; Danchin N Circulation; 2011 Feb; 123(5):474-82. PubMed ID: 21262992 [TBL] [Abstract][Full Text] [Related]
7. Clopidogrel, genetics, and drug responsiveness. Freedman JE; Hylek EM N Engl J Med; 2009 Jan; 360(4):411-3. PubMed ID: 19164193 [No Abstract] [Full Text] [Related]
8. Cytochrome P450 2C19 polymorphism, suboptimal reperfusion and all-cause mortality in patients with acute myocardial infarction. Małek LA; Przyłuski J; Spiewak M; Kłopotowski M; Kostrzewa G; Kruk M; Płoski R; Witkowski A; Rużyłło W Cardiology; 2010; 117(2):81-7. PubMed ID: 20924183 [TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of cytochrome P450 2C19 polymorphism and risk of adverse clinical outcomes among coronary artery disease patients of different ethnic groups treated with clopidogrel. Jang JS; Cho KI; Jin HY; Seo JS; Yang TH; Kim DK; Kim DS; Seol SH; Kim DI; Kim BH; Park YH; Je HG; Jeong YH; Lee SW Am J Cardiol; 2012 Aug; 110(4):502-8. PubMed ID: 22591668 [TBL] [Abstract][Full Text] [Related]
10. Value of platelet pharmacogenetics in common clinical practice of patients with ST-segment elevation myocardial infarction. Verschuren JJ; Boden H; Wessels JA; van der Hoeven BL; Trompet S; Heijmans BT; Putter H; Guchelaar HJ; Schalij MJ; Jukema JW Int J Cardiol; 2013 Sep; 167(6):2882-8. PubMed ID: 22940005 [TBL] [Abstract][Full Text] [Related]
11. Cytochrome P-450 polymorphisms and response to clopidogrel. Taubert D; Bouman HJ; van Werkum JW N Engl J Med; 2009 May; 360(21):2249-50; author reply 2251. PubMed ID: 19458375 [No Abstract] [Full Text] [Related]
12. Cytochrome P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated with clopidogrel. Jin B; Ni HC; Shen W; Li J; Shi HM; Li Y Mol Biol Rep; 2011 Mar; 38(3):1697-702. PubMed ID: 20845077 [TBL] [Abstract][Full Text] [Related]
14. Genotyping, clopidogrel metabolism, and the search for the therapeutic window of thienopyridines. Steinhubl SR Circulation; 2010 Feb; 121(4):481-3. PubMed ID: 20083686 [No Abstract] [Full Text] [Related]
15. Platelet inhibitors: update on clopidogrel (Plavix) and the recently approved prasugrel (Effient). Wynn RL Gen Dent; 2010; 58(1):7-9. PubMed ID: 20129886 [No Abstract] [Full Text] [Related]
16. Cytochrome P-450 polymorphisms and response to clopidogrel. Miao J; Liu R; Li Z N Engl J Med; 2009 May; 360(21):2250-1. PubMed ID: 19469033 [No Abstract] [Full Text] [Related]
17. Unraveling the pharmacogenetics of clopidogrel: the paraoxonase-1 controversy. Snoep JD Circ Cardiovasc Interv; 2011 Oct; 4(5):401-4. PubMed ID: 22010185 [No Abstract] [Full Text] [Related]
18. Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy. Scott SA; Sangkuhl K; Gardner EE; Stein CM; Hulot JS; Johnson JA; Roden DM; Klein TE; Shuldiner AR; Clin Pharmacol Ther; 2011 Aug; 90(2):328-32. PubMed ID: 21716271 [TBL] [Abstract][Full Text] [Related]
19. Genetic determinants of response to clopidogrel and cardiovascular events. Simon T; Verstuyft C; Mary-Krause M; Quteineh L; Drouet E; Méneveau N; Steg PG; Ferrières J; Danchin N; Becquemont L; N Engl J Med; 2009 Jan; 360(4):363-75. PubMed ID: 19106083 [TBL] [Abstract][Full Text] [Related]
20. Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement. Hochholzer W; Trenk D; Fromm MF; Valina CM; Stratz C; Bestehorn HP; Büttner HJ; Neumann FJ J Am Coll Cardiol; 2010 Jun; 55(22):2427-34. PubMed ID: 20510210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]